ACROSS ONCOLOGY. WORLDWIDE
Josep Tabernero
ESMO President
Wednesday, 14th February 2018
ESMO
ESMO IN A NUTSHELL
Europe’s leading Medical Oncology Society
ESMO is the leading European professional organisation for
medical oncology, working across Europe and around the world
to erase boundaries in cancer care and to provide medical
oncology education within an integrated approach to cancer
care
ESMO MISSION
Improve the quality of prevention, diagnosis, treatment, supportive
and palliative care
Disseminate knowledge in oncology to cancer patients and
the public
Facilitate equal access to optimal cancer care for all
cancer patients
Maintain liaisons with other oncology
specialties, cancer leagues, universities,
patient groups & where appropriate, the pharmaceutical
industry
Advance the art, science, recognition,
and practice of oncology
Promote education in oncology to ensure a
high standard of qualification for
medical oncologists within the
multidisciplinary team
Educate and train persons involved in
clinical cancer care and research
ESMO 2020 VISIONSecuring the best possible outcomes for people with cancer
Membership
ConferencesPublic Policy
Career Development
OncologyProClinical Practice
ESMO MEMBERSHIP AND GLOBAL NETWORK
Membership Distribution
North America 9%
South America 6%
Europe 55%
Africa 5%
Asia-Pacific 25%
As of 31 December 2017
> 18,000 members
Over 150 countries
Reciprocal membership
with 50 national oncology societies
5,661 6,306 6,7867,371 7,356
11,49613,221
15,295
18,213
0
5000
10000
15000
20000
2009 2010 2011 2012 2013 2014 2015 2016 2017
ESMO MEMBERSHIP GROWTH 2009-2017
222% increase over last 9 years
AFRICA: 875 MEMBERS
Algeria 108
Angola 2
Botswana 1
Cameroon 2Congo, Democratic Republic of 2Congo, Republic of 1
Côte d'Ivoire 1
Egypt 402
Eritrea 1
Ethiopia 2
Guinea-Bissau 1
Kenya 11
Libya 11
Malawi 1
Mali 1
Mauritania 2
Mauritius 4
Morocco 77
Namibia 6
Nigeria 13
Senegal 2
South Africa 124
Sudan 20
Tanzania 2
Tunisia 52
Uganda 8
Zambia 1
Zimbabwe 8
Membership figures at 31.12.2017
SOUTH AFRICA: 124 MEMBERS
DEVELOPING COUNTRIES DISCOUNTED FEES
ESMO offers a reduced membership fee of € 25 or € 50 to oncology professionals from developing countries.
This 'two tier' structure uses the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita and calculated using the World Bank Atlas method.
ESMO SUMMIT AFRICA SPECIAL ONSITE MEMBERSHIP OFFER
One free year of membership offered to all registered delegates
More information at the ESMO booth in the Exhibition
Jill MaddenHead of Membership
TOOLS AND RESOURCESOncologyPRO – ESMO’s online education portal
Scientific and educational online portal
Direct access 24/7 to
oncology news, scientific
and educational resources
Information by disease-type
Continuously updated
DISSEMINATING CANCER INFORMATION WORLDWIDE
The official journal of ESMO, providing rapid and efficient peer-review publications on innovative
cancer treatments, or translational work related to oncology and
precision medicine.
Ranked #10 in Oncology; IF 11.855
•Over 4.3x10 million downloads in 2016
•Accessed by 3,569 institutions worldwide
•Over 2 million unique readers in 188 countries
•Over 15,000 followers on Twitter
•Official journal of JSMO
ESMO’s online-only, peer-reviewed open access journal, dedicated to
publishing high-quality medical research and educational content from all disciplines of oncology.
Indexing: Google Scholar, PubMed Central, Emerging Sources Citation Index (Web of Science)
•Global reach: 241 submissions from 34 countries
•Broad coverage: 157 papers published
•Affiliations with AIOM, CSCO, KACO, JSMO
SETTING THE STANDARDS OF CARE FOR CLINICAL CANCER PRACTICE
ESMO Clinical Practice Guidelines
Evidence-based
guidelines to support
clinicians in delivering
patients the best cancer treatment
options
Latest information
on diagnostic criteria, disease
staging, risk assessment, treatment plan and follow-up
Regularly updated and reviewed by
leading oncology experts
More than 70 available from the
ESMO website or the ESMO
mobile app
Approximately 20 patient
friendly versions available
ESMO MEETINGS
Exchange expertise and knowledge at our first class events
Congresses Symposia Educational Courses
PROMOTING SUSTAINABLE CANCER CAREESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS)
A
B
C
5
4
3
2
1
Curative Non-curative
Since 2016 new cancer medicines or indications approved by the European Medicines Agency have been scored and presented either in the ESMO Guidelines where relevant or as an e-Update
Medicines which obtain the highest scores A and B (curative setting) 5 and 4 (non-curative setting) represent the highest priority for rapid endorsement by national bodies across Europe
ENSURING ACCESS TO CANCER MEDICINESA critical issue for medical oncologists
To treat patients according to the ESMO
Clinical Practice Guidelines, medical
oncologists need to have access to the cancer
medicines recommended in the guidelines.
In Europe ESMO works closely with the European
Medicines Agency and the European Network of
Health Technology Assessment in order to harmonise the approval
and reimbursement process for cancer
medicines in Europe.
ESMO has conducted international surveys on the availability of cancer
medicines and has proposed
recommendations on how to reduce the
barriers.
ESMO keeps its members updated on the latest in personalised medicine, immunotherapies and biosimilars in a rapidly-advancing landscape of new cancer treatments
ESMO: MEDICAL ONCOLOGY EDUCATION BROUGHT DIRECTLY TO YOU
A global society with a tailored education offer to meet your local needs
14-16 FEBRUARY 2018
ESMO SUMMIT AFRICA 2018 Cape Town, South Africa, 14 - 16 Feb
Oncology Updates: From Evidence to Practice
Designed to address the specific challenges faced by oncology professionals practising in this region
Local and international experts covering the cancer types most frequently encountered in Sub-Saharan Africa
Series of clinical case presentations followed by time for discussion
To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO annualcongress
To review the current standard of care for key malignancies from a local and international perspective
To discuss the current controversies in the management of specific cancers
PARTICIPANTS OVERVIEW
ESMO SUMMIT AFRICA 2018
Participants Category
Speakers and chairs 44
Delegates 329
ESMO Staff 2
Total 375
COUNTRY BREAK DOWN (DELEGATES)
Country Nr. of delegatesAngola 1Austria 1Belgium 3Botswana 4Congo 5Egypt 1France 7India 1Kenya 6Mauritius 1Mozambique 1Namibia 4Netherlands 1Philippines 1Romania 1South Africa 260South Korea 1Sri Lanka 1Swaziland 3Sweden 1Switzerland 4Tanzania 4Thailand 2UK 4USA 3Zambia 2Zimbabwe 6
329
79% South Africa
11,5% Africa
6,7% Europe
1,9% Asia
0,9% Other
THANK YOU
Top Related